MedPath

Lidocaine

Lidocaine Ointment - 918

Approved
Approval ID

3ea9b7ae-b05a-4415-a451-05763b3c6ffd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2017

Manufacturers
FDA

MARTIN EKWEALOR PHARMACEUTICALS, INC.

DUNS: 010759905

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code58607-918
Product Classification
G
Generic Name
LIDOCAINE
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 17, 2017
FDA Product Classification

INGREDIENTS (3)

POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
POLYETHYLENE GLYCOL 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT
LIDOCAINEActive
Quantity: 2.5 g in 50 g
Code: 98PI200987
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details